Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Aug 13, 2026
Braskem S.A. (BAK) Stock Falls -22% Over 30 Days Amid Ongoing Debt Restructuring

Braskem S.A. (BAK) Stock Falls -22% Over 30 Days Amid Ongoing Debt Restructuring

Key Takeaways

  • Braskem S.A. (BAK) has fallen about 22% over the past 30 days, from a $2.67 close on July 14, 2026, to the latest available price near $2.08 in mid-August.
  • The decline reflects unresolved debt-restructuring negotiations, creditor rejection of the company's initial proposal, and a June court-protection filing that led S&P Global Ratings to cut Braskem to 'D'.
  • Weak petrochemical spreads, polyethylene and polypropylene oversupply, and financial stress at the Braskem Idesa unit in Mexico continue to weigh on sentiment.
  • Analyst conviction has deteriorated, with several downgrades in June and July pushing consensus toward a sell/underperform view.
  • Over the trailing three months, the stock has lost roughly 58% from its May 13, 2026 close of $4.97 after touching a 52-week high.

Braskem S.A. (BAK) Company Overview and Market Position

Braskem S.A. is a Brazilian integrated petrochemical company and the largest producer of thermoplastic resins in the Americas. Its portfolio centers on polyethylene, polypropylene, and PVC, along with basic petrochemical feedstocks such as ethylene and propylene, serving packaging, automotive, construction, and consumer-goods markets. The company operates through three main segments—Brazil, the United States and Europe, and Mexico—and its American depositary shares trade on the NYSE under the BAK symbol. Following the 2026 transfer of control to IG4 Capital, with Petrobras remaining a key shareholder, investors track Braskem for exposure to the global petrochemical cycle, Brazilian industrial demand, and the company's capital-structure turnaround.

Braskem S.A. (BAK) Stock Price Performance: Last 30 Days vs. Quarter

Braskem's latest available price of $2.075 (intraday, Aug. 13, 2026) compares with the July 14, 2026 close of $2.67, producing a 30-day decline of approximately 22.3%. Within that window, selling was persistent but not uniform: the stock dropped from the $2.67 area in mid-July to a $2.04 close on Aug. 12, with the Aug. 12 session marking the sharpest single-day move at -7.7%. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

The picture is steeper over the trailing quarter. Braskem closed at $4.97 on May 13, 2026, after setting a 52-week high of $5.395 that same month. From that level, the decline to roughly $2.08 represents a loss of about 58%. The move illustrates how a brief first-quarter earnings-related advance gave way to a restructuring-driven repricing.

What Drove BAK Stock Price in the Last 30 Days

Capital-structure risk has been the dominant driver. On Aug. 12, Reuters reported that Braskem was in advanced discussions to file for out-of-court restructuring that could be submitted within August, covering more than $10 billion of debt across Brazil, the United States, and Europe; the report also noted possible parallel restructuring options for roughly $2 billion of debt at the Braskem Idesa subsidiary in Mexico. BAK shares fell 7.7% that day to $2.04.

The 30-day decline extends a restructuring-driven selloff that began in late June, when the company filed for mediation and precautionary injunctive relief after creditors rejected its initial proposal. S&P Global Ratings downgraded Braskem to 'D' from 'CCC-' on June 26, treating the court-ordered standstill as equivalent to a payment default. The protection period was subsequently reported to run through late August, leaving investors focused on whether a creditor agreement can be reached.

Analyst actions compounded the pressure. Weiss Ratings reiterated a sell-style rating in mid-July, and by late July MarketBeat data showed a consensus "Strong Sell" rating with an average price target around $3.40. With shares trading well below their 50-day and 200-day moving averages, technical selling also contributed.

What Drove BAK Stock Performance Over the Last Quarter

Over the trailing three months, Braskem shares moved from a May peak near $5.40 to the low-$2 range. The first-quarter report released on May 14 showed a sharp sequential improvement in recurring EBITDA, helped by higher spreads and operational recovery, and the stock rallied into the release. The advance proved short-lived as the broader petrochemical downcycle reasserted itself: compressed spreads, oversupply in polyethylene and polypropylene, weak demand, and liquidity strain at Braskem Idesa all returned to the foreground.

Governance and balance-sheet developments added to the pressure. A June 8 shareholder meeting approved broad bylaw changes and installed new leadership, including CEO Helcio Tokeshi. Weeks later, the company's mediation filing and the S&P downgrade to 'D' crystallized creditor concerns. Braskem's substantial Alagoas remediation liabilities and heavy near-term debt-service obligations reinforced the negative narrative, and the absence of a creditor agreement by mid-August kept the stock under sustained pressure.

BAK Stock Forecast Drivers: What Investors Should Watch Next

The restructuring timeline is the central near-term variable, including whether Braskem files for out-of-court recovery, reaches a creditor agreement, or pursues alternatives for its Brazil, U.S., and Europe debt and for Braskem Idesa. Investors should also monitor second-quarter results for EBITDA trends, cash position, leverage, and any formal guidance. Industry fundamentals matter as well: polyethylene and polypropylene spreads, resin pricing and demand, global capacity dynamics, and import conditions in Brazil. Alagoas remediation progress, analyst estimate revisions, and Brazilian currency and interest-rate conditions round out the key watchpoints. These factors carry meaningful uncertainty, and they are informational rather than a basis for investment decisions. From what I see, monitoring these elements closely remains essential given the current environment.

Using Tickeron AI Tools for Additional Perspective

In my research on names facing significant volatility, I often turn to Tickeron’s AI Trading Bots to review automated strategies that provide a range of signals across different timeframes and market conditions. These tools add a layer of data-driven insight that complements fundamental analysis without replacing it.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: BAK

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


BAK in upward trend: price may jump up because it broke its lower Bollinger Band on August 25, 2026

BAK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 44 cases where BAK's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BAK's RSI Oscillator exited the oversold zone, of 47 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on September 08, 2026. You may want to consider a long position or call options on BAK as a result. In of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BAK just turned positive on September 02, 2026. Looking at past instances where BAK's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BAK advanced for three days, in of 251 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BAK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for BAK entered a downward trend on September 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: BAK's P/B Ratio (142.857) is very high in comparison to the industry average of (10.771). BAK has a moderately low P/E Ratio (0.000) as compared to the industry average of (33.713). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (20.317). BAK has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.039). P/S Ratio (0.061) is also within normal values, averaging (0.586).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BAK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BAK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.

Notable companies

The most notable companies in this group are Dow (NYSE:DOW).

Industry description

The major diversified chemicals industry includes companies that produce a wide range of chemicals and industrial gases. The products are often used as raw materials in the manufacturing of various types of goods, including plastics, paints, carpets, and fixtures to name a few. Major companies making diversified chemicals include DuPont de Nemours Inc., Celanese Corporation, Celanese Corporation and Westlake Chemical Corporation.

Market Cap

The average market capitalization across the Chemicals: Major Diversified Industry is 2.8B. The market cap for tickers in the group ranges from 80.4K to 89.01B. SHECF holds the highest valuation in this group at 89.01B. The lowest valued company is DEVV at 80.4K.

High and low price notable news

The average weekly price growth across all stocks in the Chemicals: Major Diversified Industry was 1%. For the same Industry, the average monthly price growth was -1%, and the average quarterly price growth was -14%. BAK experienced the highest price growth at 9%, while TROX experienced the biggest fall at -6%.

Volume

The average weekly volume growth across all stocks in the Chemicals: Major Diversified Industry was 2%. For the same stocks of the Industry, the average monthly volume growth was 14% and the average quarterly volume growth was -50%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 43
P/E Growth Rating: 37
Price Growth Rating: 58
SMR Rating: 84
Profit Risk Rating: 86
Seasonality Score: -7 (-100 ... +100)
View a ticker or compare two or three
BAK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of petrochemicals and other related products

Industry ChemicalsMajorDiversified

Profile
Details
Industry
Chemicals Specialty
Address
Rua Lemos Monteiro
Phone
+55 1135769531
Employees
8233
Web
https://www.braskem.com.br
Interact to see
Advertisement
HIMS shares surged approximately +43.85% in premarket trading on Monday, March 9, 2026, rising from a prior close of $15.74 to around $22.80. Primary catalyst: Novo Nordisk officially ended its patent infringement lawsuit against Hims & Hers and announced a landmark partnership to distribute branded Wegovy through the Hims platform at $599/month.
XENE shares surged approximately +45.93% in premarket trading on March 9, 2026, one of the largest single-session moves in the company's history. The primary catalyst: Xenon announced positive topline Phase 3 X-TOLE2 results for its lead drug candidate azetukalner in focal onset seizures (FOS), meeting the primary endpoint with overwhelming statistical significance.
Shares of OLMA dropped approximately 41% in Monday's session, one of the steepest single-day declines in the company's history. The primary catalyst was Roche's Phase 3 persevERA trial failure — a late-stage study of giredestrant, a closely competing selective estrogen receptor degrader (SERD), which missed its primary endpoint of statistically significant improvement in progression-free survival.
RLMD shares surged approximately +40% at the open on March 9, 2026, rising from a prior close of $4.45 to approximately $6.23, driven by a major clinical trial readout. The primary catalyst was the announcement of 12-month interim data from the Phase 2 trial of NDV-01, Relmada's lead oncology candidate, in patients with high-risk non-muscle invasive bladder cancer (NMIBC) — results that significantly exceeded historical benchmarks.
CRCL surged +8.66% on Monday, March 9, 2026, rising from a prior close of $101.94 to trade at $110.77 intraday. The primary catalyst is a landmark stablecoin milestone: Circle's USDC overtook Tether as the dominant stablecoin by transfer volume, accounting for approximately 70% of all stablecoin transfer activity as total stablecoin transfers hit $1.8 trillion in February.
Carnival Corporation (CCL) shares fell approximately -7.60% in Monday's session, dropping from a Friday close of $25.79 to around $23.83. The primary catalyst is a broad market sell-off driven by intensifying recession fears, with the S&P 500 and consumer discretionary names bearing the brunt of the pressure.
Shares of Bloom Energy (BE) are surging approximately +10.30% in Monday's session, rebounding sharply from a steep -15.50% selloff on Friday, March 6, 2026. Friday's decline was triggered by an Oracle-OpenAI data center project update that spooked energy infrastructure investors; Monday's move reflects aggressive dip-buying and a sentiment reset.
IGV has rallied about 8–9% in the last 6 trading days, while SOXX has dropped about 8%, giving software a +16.6 percentage‑point edge—the largest 6‑day software‑over‑semi outperformance ever.[barchart]​ This comes right after software lagged semis by almost −15 percentage points into late January, the widest gap since 2008, and as hedge‑fund short exposure to U.S. software and services hit a record ~3.8% of market cap.
Crude’s explosive war‑driven spike faded on March 9 because the market suddenly started to price less extreme, shorter‑lived supply risk and more policy intervention, not a multi‑month shortage. WTI, which had briefly traded above 115–120 dollars on Iran‑war headlines and Strait of Hormuz fears, slid back toward the high‑80s as traders digested G7 reserve‑release talk, Trump’s comments about a “brief” war, and the reality that prices had run far ahead of fundamentals.
Shares of ARQ plunged approximately 27.50% in premarket trading on March 10, 2026, from a prior close of $3.20 to roughly $2.32. The primary catalyst was a deeply disappointing Q4 2025 earnings report, which revealed a net loss of $50.0 million for the quarter versus a net loss of $1.3 million in Q4 2024.
RAIL shares fell approximately 15% in premarket trading on March 10, 2026, following a steep after-hours reaction to disappointing Q4 2025 earnings results released after the close on March 9. The primary catalyst was a significant revenue miss: Q4 revenue came in at $125.6 million, well below consensus estimates near $144–$160 million, representing an 8.8% year-over-year decline.
ZVRA shares surged approximately +17.86% on March 10, 2026, driven by a blockbuster Q4 and full-year 2025 earnings report released before the market open. Primary catalyst: Q4 2025 EPS of $0.19 crushed the consensus estimate of $0.05 — a 280% beat — while revenue of $34.1 million exceeded forecasts by 21.57%.
LITE surged +14.73% on Monday, March 9, 2026, closing at $640.69 versus a prior close of $558.44 on March 6. The primary catalyst was the landmark $2 billion strategic investment by NVIDIA announced March 2, with the market continuing to price in its full implications following a brief post-announcement pullback.
Shares of BNTX fell approximately 22% on Tuesday, March 10, 2026, following a dual shock of disappointing full-year guidance and a surprise leadership upheaval. The primary catalyst was BioNTech's Q4 2025 earnings report, which included a 2026 revenue outlook of €2.0–€2.3 billion — well below analyst consensus and signaling continued pressure from declining COVID-19 vaccine demand.
CNC shares fell approximately 10% during Tuesday's session, extending a prolonged selloff in the managed care sector. The primary catalyst is intensifying investor concern over federal Medicaid and ACA funding cuts tied to the "One Big Beautiful Bill Act" (OBBBA), which threatens to shrink the government-sponsored insurance pools that Centene depends on for the majority of its revenue.
Technology recently peaked near 35% of the S&P 500 and has slipped over the last year, while Energy plus Materials remain near historically low combined weight at roughly 6%, which suggests the gap is still unusually wide.
Average daily equity purchases by retail investors on S&P 500 down days in 2026 are at the highest level on record, running about 100% above the peak intensity seen during the 2021 meme‑stock boom.
Over the past two weeks, PLTR has climbed from roughly the high‑130s to the mid‑150s, a gain of about 12–14%, with a series of strong up days between March 2 and March 6.
AVAV shares dropped approximately 10% in premarket trading on March 11, 2026, following a disappointing Q3 fiscal 2026 earnings report released after the prior session's close. Q3 revenue of $408.0 million came in far below analyst consensus of approximately $475–$488 million, representing a massive top-line miss.
KOS shares are down approximately 20% in premarket trading on March 11, 2026, having shed roughly 20.31% across the last two sessions (Tuesday close and premarket Wednesday). The primary catalyst is Kosmos Energy's announcement of a massive $185.25 million public equity offering priced at $1.90 per share — a steep discount to recent trading levels.